The consumer-genomics company 23andMe just sold its biobank of customer genetic data to drugmaker Regeneron for $256 million.

Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.

  • Doomsider@lemmy.world
    9·
    13 hours ago

    Unfortunately, it is too late. They don’t need your specific genetic code to extrapolate about you, just the code of one of your relatives who wanted to find out their heritage for fun.

    Without serious privacy laws we will be used and abused by corporations, get ready to experience Gattaca in real life.